Rituximab for people with multiple sclerosis [protocol].

Filippini, Graziella; Kruja, Jera; He, Dian; Del Giovane, Cinzia (2021). Rituximab for people with multiple sclerosis [protocol]. (In Press). Cochrane database of systematic reviews(2), CD013874. WileyInterscience 10.1002/14651858.CD013874

[img] Text
Filippini_CochraneDatabaseSystRev_2021.pdf - Published Version
Restricted to registered users only until 17 February 2022.
Available under License Publisher holds Copyright.

Download (263kB) | Request a copy

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

The main objective is to assess the benefits and harms of rituximab compared to placebo or another DMT for people with multiple sclerosis.

Specific comparisons include:

rituximab compared with placebo or other DMTs as first choice treatment for relapsing forms of MS;

rituximab when switching from another DMT compared with placebo or other DMTs for relapsing forms of MS;

rituximab compared with placebo or other DMTs as first choice treatment for progressive forms of MS; and

rituximab when switching from another DMT compared with placebo or other DMTs for progressive forms of MS.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)

UniBE Contributor:

Del Giovane, Cinzia

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1469-493X

Publisher:

WileyInterscience

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

08 Apr 2021 10:08

Last Modified:

09 Apr 2021 06:53

Publisher DOI:

10.1002/14651858.CD013874

BORIS DOI:

10.48350/155684

URI:

https://boris.unibe.ch/id/eprint/155684

Actions (login required)

Edit item Edit item
Provide Feedback